World Library  
Flag as Inappropriate
Email this Article

Muller's morphs

Article Id: WHEBN0008377764
Reproduction Date:

Title: Muller's morphs  
Author: World Heritage Encyclopedia
Language: English
Subject: Mutation, Null allele, ID4, Classical genetics, Genetics
Collection: Classical Genetics, Genetics, Mutation
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Muller's morphs

Neomorph redirects here. It is also one of the post-human types of persons in the novel Eon by Greg Bear.

1946 Nobel Prize winner Hermann J. Muller (1890-1967) coined the terms amorph, hypomorph, hypermorph, antimorph and neomorph [1] to classify mutations based on their behaviour in various genetic situations. These classifications are still widely used in Drosophila genetics to describe mutations. For a more general description of mutations, see mutation, and for a discussion of allele interactions, see dominance relationship.

Key: In the following sections, alleles are referred to as +=wildtype, m=mutant, Df=gene deletion, Dp=gene duplication. Phenotypes are compared with '>', meaning 'phenotype is more severe than'

Contents

  • Loss of function 1
    • Amorph 1.1
    • Hypomorph 1.2
  • Gain of function 2
    • Hypermorph 2.1
    • Antimorph 2.2
    • Neomorph 2.3
  • References 3

Loss of function

Amorph

Amorphic describes a mutation that causes complete loss of gene function.[1] Amorph is sometimes used interchangeably with "genetic null". An amorphic mutation might cause complete loss of protein function by disrupting translation ("protein null") and/or preventing transcription ("RNA null").

An amorphic allele elicits the same phenotype when homozygous and when heterozygous to a chromosomal deletion or deficiency that disrupts the same gene.[2] This relationship can be represented as follows:

m/m = m/Df

An amorphic allele is commonly recessive to its wildtype counterpart. It is possible for an amorph to be dominant if the gene in question is required in two copies to elicit a normal phenotype (i.e. haploinsufficient).

Hypomorph

Hypomorphic describes a mutation that causes a partial loss of gene function.[1] A hypomorph is a reduction in gene function through reduced (protein, RNA) expression or reduced functional performance, but not a complete loss.

The phenotype of a hypomorph is more severe in trans to a deletion allele than when homozygous.[2]

m/Df > m/m

Hypomorphs are usually recessive, but occasional alleles are dominant due to haploinsufficiency.

Gain of function

Hypermorph

A hypermorphic mutation causes an increase in normal gene function.[1] Hypermorphic alleles are gain of function alleles. A hypermorph can result from an increase in gene dose (a gene duplication), from increased mRNA or protein expression, or constitutive protein activity.

The phenotype of a hypermorph is worsened by increasing the wildtype gene dose, and is reduced by lowering wildtype gene dose.[2]

m/Dp > m/+ > m/Df

Antimorph

Antimorphs are dominant mutations that act in opposition to normal gene activity.[1] Antimorphs are also called dominant negative mutations.

Increasing wildtype gene function reduces the phenotypic severity of an antimorph, so the phenotype of an antimorph is worse when heterozygous than when in trans to a gene duplication.[2]

m/+ > m/Dp

An antimorphic mutation might affect the function of a protein that acts as a dimer so that a dimer consisting of one normal and one mutated protein is no longer functional.

Neomorph

A Neomorphic mutation causes a dominant gain of gene function that is different from the normal function.[1] A neomorphic mutation can cause ectopic mRNA or protein expression, or new protein functions from altered protein structure.

Changing wildtype gene dose has no effect on the phenotype of a neomorph.[2]

m/Df = m/+ = m/Dp

References

  1. ^ a b c d e f Muller, H. J. 1932. Further studies on the nature and causes of gene mutations. Proceedings of the 6th International Congress of Genetics, pp. 213–255.
  2. ^ a b c d e Wilkie, A. O. 1994. The molecular basis of genetic dominance. Journal of Medical Genetics 31: 89-98.
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 



Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.